Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

2 Group Education Programs for Fatigue Compared

Mult Scler; ePub 2018 May 15; Hugos, Cameron, et al

Publish date:: May 30, 2018

The delayed effect on fatigue of Fatigue: Take Control (FTC), a multicomponent group program, suggests the need for longer follow-up when assessing interventions for fatigue, according to a recent 4-site randomized controlled trial that found no significant differences from a control program in fatigue, MS: Take Control (MSTC), on the Modified Fatigue Impact Scale (MFIS) through 6 months. Of 78 subjects at 1 site, 74 randomized to FTC or MSTC completed the MFIS at 12 months. Compared to baseline, FTC produced greater improvements in MFIS scores than MSTC (FTC −8.9 [confidence interval (CI): 32.2, 45], MSTC −2.5 [CI 39.6, 47.7]) at 12 months.

Citation:

Hugos CL, Cameron MH, Chen Z, Chen Y, Bourdette D. A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site. [Published online ahead of print May 15, 2018]. Mult Scler. doi:10.1177/1352458518775920.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,